G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 478.2 INR 0.69% Market Closed
Market Cap: 417.1B INR
Have any thoughts about
Glenmark Pharmaceuticals Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Glenmark Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024
Operating Cash Flow
Net Income
10 961
12 860
13 825
15 140
14 412
15 009
8 685
3 482
5 692
Depreciation & Amortization
4 172
4 496
4 436
4 626
4 867
5 529
6 113
6 180
6 308
Other Non-Cash Items
2 191
1 918
2 013
2 585
3 004
(1 591)
8 607
17 761
3 790
Cash Taxes Paid
4 670
4 526
5 102
5 674
5 584
5 517
6 405
5 585
10 475
Cash Interest Paid
3 015
2 725
2 936
2 674
2 505
2 782
3 115
4 100
5 168
Change in Working Capital
(3 399)
(6 977)
(8 961)
(9 860)
(11 197)
(11 259)
(17 144)
(20 225)
(20 362)
Cash from Operating Activities
13 924
N/A
12 296
-12%
11 312
-8%
12 490
+10%
11 087
-11%
7 689
-31%
6 261
-19%
7 198
+15%
(4 572)
N/A
Investing Cash Flow
Capital Expenditures
(9 324)
(8 361)
(7 748)
(7 079)
(7 901)
(7 710)
(6 078)
(6 890)
(9 149)
Other Items
1 489
984
995
4 736
4 568
626
793
676
54 758
Cash from Investing Activities
(7 835)
N/A
(7 377)
+6%
(6 752)
+8%
(2 342)
+65%
(3 333)
-42%
(7 084)
-113%
(5 285)
+25%
(6 214)
-18%
45 609
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
10 265
10 119
(146)
0
0
12
Net Issuance of Debt
(747)
(2 868)
(777)
(10 276)
(11 317)
1 963
5 234
7 799
(32 728)
Cash Paid for Dividends
(686)
(685)
(704)
(1 410)
(927)
(441)
(1 366)
(1 146)
(1 178)
Other
(3 015)
(2 725)
(2 936)
(3 247)
(3 079)
(4 310)
(4 643)
(4 100)
(5 168)
Cash from Financing Activities
(4 447)
N/A
(6 277)
-41%
(4 418)
+30%
(4 669)
-6%
(5 205)
-11%
(2 934)
+44%
(775)
+74%
2 553
N/A
(39 061)
N/A
Change in Cash
Effect of Foreign Exchange Rates
98
1 066
136
(64)
176
434
124
(269)
177
Net Change in Cash
1 740
N/A
(292)
N/A
278
N/A
5 415
+1 848%
2 725
-50%
(1 895)
N/A
325
N/A
3 268
+906%
2 152
-34%
Free Cash Flow
Free Cash Flow
4 600
N/A
3 935
-14%
3 564
-9%
5 411
+52%
3 186
-41%
(21)
N/A
183
N/A
308
+68%
(13 721)
N/A

See Also

Discover More